Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ZafgenUrogen PharmaAthersysAprea TherapeuticsRadius Health
Price Information
Current Price$11.72$23.65$2.81$29.42$13.33
52 Week RangeHoldBuyBuyHoldHold
Beat the Market™ Rank
Overall Score0.
Analysis Score1.
Community Score2.
Dividend Score0.
Ownership Score1.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationHoldBuyBuyHoldHold
Consensus Price Target$0.78$45.20$9.00$35.80$25.57
% Upside from Price Target-93.34% downside91.12% upside220.28% upside21.69% upside91.83% upside
Trade Information
Market Cap$439.15 million$512.81 million$569.78 million$648.70 million$615.58 million
Average Volume360,199216,0686,272,231240,597506,062
Sales & Book Value
Annual RevenueN/A$20,000.00$5.63 millionN/A$173.32 million
Price / SalesN/A24,710.7098.07N/A3.57
Price / CashN/AN/AN/AN/AN/A
Book Value$1.35 per share$8.63 per share$0.15 per share$5.92 per share($0.92) per share
Price / BookN/A2.7418.73N/A-14.49
Net Income$-45,410,000.00$-105,150,000.00$-44,580,000.00$-28,060,000.00$-132,990,000.00
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-66.82%
Return on Equity (ROE)-51.34%-63.41%-184.41%N/AN/A
Return on Assets (ROA)-34.55%-58.23%-104.23%N/A-57.31%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.26%N/AN/AN/AN/A
Current Ratio6.56%8.58%2.36%10.79%3.05%
Quick Ratio6.56%8.58%2.36%10.79%2.95%
Ownership Information
Institutional Ownership Percentage70.43%64.41%17.29%63.84%N/A
Insider Ownership Percentage14.20%12.00%12.60%52.20%2.92%
Shares Outstanding37.47 million20.90 million196.48 million21.06 million46.39 million
Next Earnings Date8/13/2020 (Estimated)8/14/2020 (Estimated)8/5/2020 (Estimated)8/21/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.